This is inform you that as per Regulation 32 of SEBI LODR, Regulations,2015 Company have not any Public Issue, Right Issue, QIP. Therefore the Statement of Deviation is Not Applicable for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd has submitted a routine compliance filing to BSE stating that Regulation 32 of SEBI's Listing Obligations and Disclosure Requirements (LODR) does not apply to the company for the quarter ended 31 December 2025. Regulation 32 requires companies to report any deviation or variation in the use of funds raised through public issues, rights issues, preferential issues, or qualified institutional placements (QIPs). The company confirmed it has not undertaken any such fund-raising activity, making the statement not applicable. The declaration was signed by Director Vijaya Mani (DIN: 11363910) and filed on 2 January 2026.
This is a routine, neutral filing with no material impact on shareholders or the stock price. It simply confirms the company has not raised capital through public, rights, preferential, or QIP routes during the quarter, so no fund-use deviation report is required.